Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.
Garg R, Liu Q, Van Kessel J, Asavajaru A, Uhlemann EM, Joessel M, Hamonic G, Khatooni Z, Kroeker A, Lew J, Scruten E, Pennington P, Deck W, Prysliak T, Nickol M, Apel F, Courant T, Kelvin AA, Van Kessel A, Collin N, Gerdts V, Köster W, Falzarano D, Racine T, Banerjee A.
Garg R, et al.
Vaccine. 2024 May 19:S0264-410X(24)00586-3. doi: 10.1016/j.vaccine.2024.05.028. Online ahead of print.
Vaccine. 2024.
PMID: 38769033
Free article.
We demonstrate that these linked subunit vaccines when combined with Sepivac SWE, a squalene in water emulsion (SWE) adjuvant, are immunogenic in Syrian hamsters and subsequently provide protection from infection with SARS-CoV-2 VOCs Omicron (BA.1), Delta, and Beta. …
We demonstrate that these linked subunit vaccines when combined with Sepivac SWE, a squalene in water emulsion (SWE) adjuvant, …